Advanced Search
Contact | Corporate | Help

Phase I/II Study of Recombinant Human Interferon-Gamma (rIFN-Gamma) in HIV-Infected Children

Sponsors:
  • National Institute of Allergy and Infectious Diseases (NIAID)
  • Genentech
Phases:
  • Phase I
IndicationsAcronym:
  • HIV Infections
Age Groups:
  • Child
Gender:
Both
Names:
  • Drug: Interferon gamma-1b
Enrollment:
20

Additional information about NCT00000761.


SourceSolution © 2008-2012